{"product_id":"harvard-infectious-diseases-in-adults-2024","title":"Harvard Infectious Diseases in Adults 2024","description":"\u003cdiv class=\"views-field views-field-title\"\u003e\u003cspan class=\"field-content\"\u003eInfectious Diseases in Adults\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv class=\"views-field views-field-field-course-slogan\"\u003e\n\u003cdiv class=\"field-content\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"views-field views-field-field-course-date-display\"\u003e\n\u003cdiv class=\"field-content\"\u003eLive Streaming • April 29 – May 3, 2024\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e65 videos + 49 pdf, size: 25.9 GB\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch4\u003eState-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases\u003c\/h4\u003e\n\u003cem\u003eInfectious Diseases in Adults will be held online this year, using live streaming technology and electronic and live question and answer sessions. \u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eOVERVIEW\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eOptimal decision-making in the prevention, diagnosis, and treatment of infectious diseases\u003c\/li\u003e\n\u003cli\u003eNewer antimicrobials and treatment strategies for highly resistant infections\u003c\/li\u003e\n\u003cli\u003eThe latest on COVID-19, including long COVID\u003c\/li\u003e\n\u003cli\u003ePrevention and treatment of infections in immunocompromised hosts\u003c\/li\u003e\n\u003cli\u003eUpdate on antifungal diagnostics and therapy\u003c\/li\u003e\n\u003cli\u003eState-of-the-art and multidisciplinary approaches to common infections\u003c\/li\u003e\n\u003cli\u003eClinical approaches to complex, rare, and “don’t-miss” infections\u003c\/li\u003e\n\u003cli\u003eInfections in persons with substance use disorder\u003c\/li\u003e\n\u003cli\u003eWhat’s new in HIV prevention and management\u003c\/li\u003e\n\u003cli\u003eNew, evolving, emerging, and re-emerging infectious diseases\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eAs revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.\u003cbr\u003e\u003cstrong\u003eHighlights of the 2024 Program\u003c\/strong\u003e\n\u003cbr\u003e\u003ch4\u003e\u003cstrong\u003eExpanded Case-Based and Problem-Solving Education \u003c\/strong\u003e\u003c\/h4\u003e\n\u003cbr\u003eThe 2024 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions of our national experts in live question-and-answer sessions following the lectures and the workshops. Our speakers and panelists include not only ID experts, but those from fields such as surgery, radiology, cardiology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care. Our twelve multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, native and prosthetic valve endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections.\u003cbr\u003e\u003ch4\u003e\u003cstrong\u003eTreating Highly Resistant Infections, including:\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eMRSA and VISA (vancomycin-intermediate \u003cem\u003eStaph aureus\u003c\/em\u003e)\u003c\/li\u003e\n\u003cli\u003eExtended spectrum beta-lactamase (ESBL)-producing Gram-negative rods\u003c\/li\u003e\n\u003cli\u003eCarbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms\u003c\/li\u003e\n\u003cli\u003eVancomycin-resistant enterococci (VRE)\u003c\/li\u003e\n\u003cli\u003eAspergillus and non-aspergillus mold infections\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003eCandida auris\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003eNontuberculous mycobacteria (NTM)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eCommon Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cbr\u003eUpdates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRespiratory viral infections, including COVID-19\u003c\/li\u003e\n\u003cli\u003eNew and updated vaccines\u003c\/li\u003e\n\u003cli\u003eInfections in the expanding populations of immunocompromised hosts\u003c\/li\u003e\n\u003cli\u003eInfections in persons with substance use disorder\u003c\/li\u003e\n\u003cli\u003eInfections of travelers and foreign-born persons\u003c\/li\u003e\n\u003cli\u003eSystemic fungal infections\u003c\/li\u003e\n\u003cli\u003eNative and device-related orthopedic infections\u003c\/li\u003e\n\u003cli\u003eCentral nervous system (CNS) infections\u003c\/li\u003e\n\u003cli\u003eEar, nose and throat (ENT) and eye infections\u003c\/li\u003e\n\u003cli\u003eBronchiectasis and pneumonia\u003c\/li\u003e\n\u003cli\u003eHIV and its infectious and noninfectious complications\u003c\/li\u003e\n\u003cli\u003ePEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection\u003c\/li\u003e\n\u003cli\u003eSexually transmitted infections (STIs), including mpox and PEP for prevention of STIs\u003c\/li\u003e\n\u003cli\u003eHepatitis B and C infections\u003c\/li\u003e\n\u003cli\u003eTick- and mosquito-borne infections\u003c\/li\u003e\n\u003cli\u003e\n\u003cem\u003eClostridioides difficile\u003c\/em\u003e infection\u003c\/li\u003e\n\u003cli\u003eComplicated urinary tract infections\u003c\/li\u003e\n\u003cli\u003eIntra-abdominal infections\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eChallenging, Rare, and Emerging Infectious Diseases\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cbr\u003eComprehensive updates on:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRare and emerging infectious diseases, including Rift Valley Fever\u003c\/li\u003e\n\u003cli\u003eRe-emergence of vaccine-preventable diseases, including poliomyelitis\u003c\/li\u003e\n\u003cli\u003ePulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including \u003cem\u003eMycobacterium abscessus\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eGlobal infectious diseases of clinical importance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eClinical Decision-Making\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cbr\u003eHear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSelecting the best antimicrobial and duration of treatment\u003c\/li\u003e\n\u003cli\u003eRapid detection and empiric treatment of life-threatening infectious diseases\u003c\/li\u003e\n\u003cli\u003eChoosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials\u003c\/li\u003e\n\u003cli\u003eOptimizing empiric antimicrobial therapy: what to start, and when to narrow or stop\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eOur multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAntimicrobial stewardship to prevent resistance and reduce cost\u003c\/li\u003e\n\u003cli\u003eInfection control\u003c\/li\u003e\n\u003cli\u003eEarly inpatient ID consultations to improve outcomes\u003c\/li\u003e\n\u003cli\u003eStrategies for management of infection in persons who inject drugs (PWID)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954329751650,"sku":"MED-AMB01583","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Infectious-Diseases-in-Adults-2024-1.jpg?v=1779371529","url":"https:\/\/meducourse.com\/products\/harvard-infectious-diseases-in-adults-2024","provider":"Meducourse","version":"1.0","type":"link"}